Skip to content

A Randomized Controlled Trial of Acupuncture for Menopausal Hot Flashes

A Randomized Controlled Trial of Acupuncture for Menopausal Hot Flashes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071084
Enrollment
Unknown
Registered
2023-05-04
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Interventions

Treatment group:Acupuncture
Control group:Acupuncture

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of menopausal syndrome of Chinese medicine and Western medicine, 2) Age between 40-55 years, 3) Variability in menstrual cycle length with a difference of 7 days in the past 10 months for at least two times, or the occurrence of amenorrhea for 2 months to 48 months, 4) Have at least 3 hot flashes daily, or a mean HF score of at least 6, 5) Sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Cryptogenic irregular vaginal bleeding, with heavy and non-stop blood flow, 2) Ovarian cyst, breast cancer, ovarion tumor, pelvic malignance tumor, 3) Oophorectomy, or hysterectomy, 4) History of radiotherapy or chemotherapy, 5) Received hormone replacement therapy 12 weeks prior to enrollment, 6) Received phytoestrogens, serotonin-reuptake inhibitors, selective serotonin and norepinephrine dual reuptake inhibitors, gabapentin, clonidine, black cohosh, traditional Chinese medicineor, or other alternative therapies 4 weeks prior to enrollment; 7) Severe primary systemic diseases such as cardiovascular, cerebrovascular, liver, kidney, and blood system diseases, or severe mental illness 8) Has contraindication of acupuncture, including infection or severe skin damage at the acupoints, dizziness or fear towards acupuncture, metal allergies, etc.

Design outcomes

Primary

MeasureTime frame
Hot Flash Score;

Secondary

MeasureTime frame
Kupperman index;Menopause Rating Scale;Menopause-Specific Quality of Life Questionnaire;Self-rating Anxiety Scale;Self-rating Depression Scale;

Countries

China

Contacts

Public ContactZHAO Ji-ping

China Beijing Dong Cheng Qu, Hai Yun Cang Hu Tong no.5, Dongzhimen Hospital

zjp7883@sina.com+86 13621382136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026